Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 856 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioVie Inc | BIVI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0106 | 2.14% | 0.5056 | 04:53:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.495 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 17 | 856 | - | 0.445 - 8.69 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 04:53:48 | 10 | US$ 0.4947 | USD |
BioVie Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.54M | 39.87M | - | 0 | -50.26M | -1.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioVie News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/14/2024 | 04:45 | PR Newswire (US) | The Gross Law Firm Notifies Shareholders of BioVie Inc... |
| 3/11/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/11/2024 | 04:45 | PR Newswire (US) | BioVie Inc. Class Action: The Gross Law Firm Reminds BioVie.. |
| 3/07/2024 | 04:45 | PR Newswire (US) | Contact The Gross Law Firm by March 19, 2024 Deadline to.. |
| 3/06/2024 | 16:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/04/2024 | 16:28 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 3/04/2024 | 16:28 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 3/04/2024 | 06:50 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/01/2024 | 16:27 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 3/01/2024 | 08:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/26/2024 | 04:45 | PR Newswire (US) | The Gross Law Firm Notifies BioVie Inc. Investors of a Class.. |
| 2/09/2024 | 04:45 | PR Newswire (US) | The Gross Law Firm Reminds BioVie Investors of the Pending.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIVI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.481 | 0.524 | 0.46925 | 0.4947087 | 761,301 | 0.0246 | 5.11% |
| 1 Month | 0.5453 | 0.5499 | 0.445 | 0.4899031 | 836,939 | -0.0397 | -7.28% |
| 3 Months | 1.04 | 3.31 | 0.445 | 1.39 | 2,809,596 | -0.5344 | -51.38% |
| 6 Months | 3.13 | 5.82 | 0.445 | 1.65 | 1,692,346 | -2.62 | -83.85% |
| 1 Year | 7.81 | 8.69 | 0.445 | 2.01 | 969,593 | -7.30 | -93.53% |
| 3 Years | 16.00 | 19.10 | 0.445 | 3.73 | 508,455 | -15.49 | -96.84% |
| 5 Years | 10.50 | 46.0977 | 0.445 | 4.30 | 435,962 | -9.99 | -95.18% |
BioVie Description
| BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism. |
